Tofacitinib for treating juvenile idiopathic arthritis

Equality Impact Assessment (Guidance development) (PDF 141 KB)

Final draft guidance

Final appraisal document (PDF 194 KB)

Committee papers (PDF 2.27 MB)

Final scope (PDF 221 KB)

Final stakeholder list (PDF 184 KB)

Equality impact assessment (Scoping) (PDF 125 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 287 KB)

Draft scope post referral (PDF 234 KB)

Draft matrix post referral (PDF 180 KB)